In this episode of MedTech Global Insights, we break down the practical application of ISO 14971:2019, the essential standard for medical device risk management. We move beyond theory to provide a clear, step-by-step framework for identifying, analyzing, and controlling risks throughout your product's lifecycle. This isn't just about ticking a compliance box. It's about building safer products, creating stronger regulatory submissions, and avoiding costly post-market surprises. We explore the common pitfalls companies face and provide actionable insights to ensure your risk management process is robust, effective, and aligned with regulator expectations globally. Consider this real-world scenario. A company launched an innovative infusion pump, but a seemingly minor software bug went undetected during a basic risk analysis. This bug caused intermittent dosage miscalculations, leading to several adverse events and a multi-million dollar product recall. A proper ISO 14971 process would have analyzed the full sequence of events from hazard to harm, forcing a design-level fix and preventing the disaster. In This Episode: * Why is a 'living' Risk Management Plan more than just a document? * How can you move beyond basic FMEA to identify the true sequence of events leading to patient harm? * What are the three critical levels of risk control, and which one do regulators prioritize? * When is a Benefit-Risk Analysis absolutely required, and what evidence must you provide? * How do you define an 'acceptable' risk without relying on subjective opinions? * What is the crucial difference between a hazard, a hazardous situation, and harm? * Why is planning for 'reasonably foreseeable misuse' essential for your product's safety profile? * How does post-market data create a continuous loop for your risk management file? For more information and expert regulatory guidance, contact us at [email protected] or visit https://pureglobal.com/